Evaluating 10-year overall survival of breast cancer patients under 35 years of age at K Hospital
Main Article Content
Abstract
Young age is an independent prognostic factor of breast cancer. This retrospective study assessed the overall survival (OS) rate by reviewing longitudinal follow-up records of 92 women under 35 years who had breast cancer and had definitive treatment from K hospital between January, 2008 and August, 2011. Five, seven and ten-year OS rate were 79.5%, 66.2 % and 64.6%, respectively. There were 34 patients (37%) who had recurrence of cancer. Five, seven and ten-year event-free survival (EFS) rate were 66.0%, 63.7% and 60.5%, respectively. Stage and lymph node metastasis were significantly associated with OS and EFS. However, there were no significant differences of EFS and OS between groups with different ER/PR. Breast cancer in young women has unfavorable EFS and OS rates.
Article Details
Keywords
breast cancer, young women, overall survival - OS, event free survival - EFS
References
2. Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res. 2010;12(5):212. doi: 10.1186/bcr2647.
3. Nguyễn Bá Đức, Bùi Diệu, Trần Văn Thuấn. Tình hình mắc ung thư tại Việt Nam năm 2010 qua số liệu của 6 vùng ghi nhận giai đoạn 2004-2008. Tạp chí Ung thư học Việt Nam. 2010;1:73-80.
4. Ahn SH, Son BH, Kim SW, et al. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-a report from the Korean Breast Cancer Society. J Clin Oncol. 2007;25(17):2360-2368. doi: 10.12 00/JCO.2006.10.3754.
5. Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur J Cancer. 2003;39(18):2632-2642. doi: 10.1016/s0959-8 049(03)00669-5.
6. Tạ Văn Tờ, Lê Phong Thu. Nhận xét một số đặc điểm mô bệnh học và hóa mô miễn dịch Carcinom tuyến vú < 35 tuổi tại Bệnh viện K. Tạp chí Y học thành phố Hồ Chí Minh. 2009;13(6):718-723.
7. Nguyễn Thế Thu. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng, kết quả điều trị bệnh ung thư vú ở phụ nữ dưới 40 tuổi tại Bệnh viện K. Luận văn tốt nghiệp bác sỹ nội trú bệnh viện. Trường Đại học Y Hà Nội; 2008.
8. Tạ Văn Tờ. Nghiên cứu hình thái học, hoá mô miễn dịch và giá trị tiên lượng của chúng trong ung thư biểu mô tuyến vú. Luận án Tiến sĩ Y học. Trường Đại học Y Hà Nội; 2004.
9. Keegan THM, DeRouen MC, Press DJ, Kurian AW, Clarke CA. Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res. 2012;14(2):R55. doi: 10.1186/bcr3156.
10. El Saghir NS, Seoud M, Khalil MK, et al. Effects of young age at presentation on survival in breast cancer. BMC Cancer. 2006;6:194. doi: 10.1186/1471-2407-6-194.
11. Zouzoulas D, Tsolakidis D, Gitas G, et al. Breast cancer in women younger than 35 years old. Arch Gynecol Obstet. 2020;302(3):721-730. doi: 10.1007/s00404-020-05695-z.
12. Zujewski J, Liu ET. The 1998 St. Gallen’s Consensus Conference: an Assessment. JNCI: Journal of the National Cancer Institute. 1998;90(21):1587-1589. doi: 10.1093/jnci/90.21.1587.
13. Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4). Ann Oncol. 2020;31(6):674-696. doi: 10.1016/j.annonc.20 20.03.284.
14. Vu Hong T. Prognostic and Predictive Factors in Vietnamese Breast Cancer : A Comparison with Swedish Patients and Effect on Survival. Inst för onkologi-patologi. Dept of Oncology-Pathology; 2012. Accessed September 30, 2020. http://openarchive.ki.se/xmlui/handle/10616/40909.
15. van der Hage JA, Mieog JSD, van de Vijver MJ, van de Velde CJH. European Organization for Research and Treatment of Cancer. Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis. Breast Cancer Res. 2007;9(5):R70. doi: 10.118 6/bcr1778.